Skip to main content

Rapid and Near-Patient Tests to Monitor and Guide Therapy in Sickle Cell Disease

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Mar 4, 2016
Award amount: 
Organization name: 
BioMedomics, Inc.
Principal Investigator: 
Wang, Frank
Grant program category: 
Business Financing
Grant program name: 
Small Business Research Loan
Research Triangle

Biomedomics proposes to develop innovative Point of Care tests for the quantitative measurement of hemoglobins S and F for Sickle Cell Disease patients receiving transfusion or hydroxyurea therapy. Real time measurements of these clinical markers will both reduce costs and improve patient outcomes over current central laboratory diagnostic options.

Fiscal year: